<DOC>
	<DOCNO>NCT00042770</DOCNO>
	<brief_summary>RATIONALE : It yet know whether pleurodesis use chest tube infusion talc effective improving quality life pleurodesis use small catheter treat malignant pleural effusion . PURPOSE : Randomized phase III trial compare effectiveness chest tube talc small catheter treat malignant pleural effusion patient cancer .</brief_summary>
	<brief_title>Standard Chest Tube Compared With Small Catheter Treating Malignant Pleural Effusion Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare success rate patient cancer undergo pleurodesis use standard chest tube talc slurry v small ( PleurX ) catheter treatment symptomatic unilateral malignant pleural effusion . - Compare 30-day effusion control rate patient treat procedure . - Compare quality life patient 7-14 30-37 day treatment procedure . - Compare patient acceptance satisfaction treatment procedure . - Compare level symptom dyspnea experienced patient treat procedure . - Compare type , cause , rate early technical failure procedures patient . - Compare 30-day effusion recurrence patient treat procedure . - Compare 60-day durability pleurodesis patient treat procedure . - Compare mortality , morbidity , common surgical complication patient treat procedure . OUTLINE : This randomize , multicenter study . Patients stratify accord inpatient status ( yes v ) , disease type ( breast v lung v ) , concurrent systemic chemotherapy ( yes v ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo placement standard pleural chest tube . Within 36 hour chest tube placement , patient undergo pleurodesis comprise intrapleural administration talc slurry follow clamp chest tube 2 hour different patient position use distribute talc . The chest tube unclamped allow continuous drainage . When chest tube drainage le 150 mL 24 hour , pleurodesis assume chest tube remove . - Arm II : Patients undergo pleurodesis comprise placement small ( PleurX ) catheter follow pleural drainage 90 minute daily . When catheter drainage le 30 mL per day 3 consecutive day , pleurodesis assume catheter remove . Quality life dyspnea assess baseline 7-14 30-37 day treatment . Patients follow 30 60 day .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Radiologic evidence unilateral malignant pleural effusion require sclerosis ongoing drainage symptomatic ( dyspnea and/or progressive fatigue ) An asymptomatic patient eligible patient underwent prior thoracentesis within past 2 week symptomatic procedure No bilateral effusion plain chest xray Histologically cytologically confirm solid tumor hematologic malignancy Histologic confirmation malignant cell pleural fluid require Pleural space must naive pleurodesis attempt No prior intrapleural therapy ( define chest tube place place drain effusion , prior surgical pleurectomy , prior chemical mechanical pleurodesis ipsilateral side ) Placement small interventional radiology catheter temporary drainage consider intrapleural therapy long sclerosant medication give place longer 10 day PATIENT CHARACTERISTICS : Age 18 Performance status CTC 02 Hematopoietic Granulocyte count least 1,500/mm^3 Platelet count least 100,000/mm^3 Pulmonary No active pleural infection Other No allergy talc No surgical contraindication talc usage Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Chemotherapy Concurrent systemic chemotherapy allow Radiotherapy Concurrent palliative radiotherapy symptomatic lesion allow except treat hemithorax within 30 day drainage procedure Surgery See Disease Characteristics Prior thoracotomy without specific pleural ablation ( include lobectomy pneumonectomy ) allow Prior needlebased diagnostic intervention ( fineneedle aspiration , small bore catheter drainage le 10 day , thoracentesis ) allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>malignant pleural effusion</keyword>
	<keyword>pulmonary complication</keyword>
</DOC>